Intero Biosystems wants drugmakers to test on mini human intestines, not animals

October 14, 2026 Kate Park

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

Previous Article
Gudea leverages AI to help organizations prevent social media crises before they erupt
Gudea leverages AI to help organizations prevent social media crises before they erupt

Gudea, a company that tracks how stories and rumors spread online that describes itself as the “storm track...

Next Article
CedarDB wants one database to handle both transactions and analytics, as AI agents raise the stakes
CedarDB wants one database to handle both transactions and analytics, as AI agents raise the stakes

Databases have traditionally been designed either for analytical data or for operational data. But database...